drugset
drugset / Trial / NCT07373756

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

NCT07373756 ↗

Phase 4 Not yet recruiting 86 enrolled Dr. Sunita Pun
RandomizedParallel-groupOpen-labelPrevention

Summary

Preeclampsia in pregnancy is a dreaded complication which has both fetal and maternal adverse outcomes. Studies and WHO have advocated that this complication can be prevented by Aspirin. However which dose is more effective in preventing preeclampsia, whether 75mg or 150mg, will be known from this study.

Timeline

Start
2026-01-15
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg Oral
Subject Aspirin Small molecule 150 mg Oral

Indications

hypertension, pregnancy-induced